| 10.76 -0.04 (-0.37%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Enfusion, Inc. supplies cloud-based software solutions designed for the investment management sector, operating throughout the United States, Europe, the Middle East, Africa, and the Asia Pacific. Its product suite includes a sophisticated portfolio management system, which establishes an instant and comprehensive investment record. This system incorporates valuation and risk assessment tools, allowing chief investment officers (CIOs) and portfolio managers to analyze aggregated or granular portfolio data. The company also offers an order and execution management system, enabling portfolio managers, traders, compliance teams, and analysts to electronically transmit and manage trade orders across various asset classes. This system simultaneously enforces trading regulations and internal operational guidelines. Additionally, Enfusion provides an accounting and general ledger system that serves as a real-time financial book of record, vital for chief financial officers (CFOs), chief operating officers (COOs), accountants, and operations teams. Furthermore, the Enfusion analytics system empowers CIOs, portfolio managers, traders, and analysts to scrutinize portfolios over different timeframes and automatically generate customized visual reports for both internal and external stakeholders. Complementing these software offerings, Enfusion also delivers technology-powered and managed services. Enfusion Inc. was founded in 2021 and is headquartered in Chicago, Illinois.
Wed, 02 Sep 2026
Paycor HCM Inc (PYCR) Peer Comparison – Compare with Others - Value Research
Mon, 31 Aug 2026
Enfusion Inc (ENFN) Peer Comparison – Compare with Others - Value Research
Sat, 29 Aug 2026
Enfusion Inc (ENFN) Key Financial Ratios – Valuation, Profitability & More - Value Research
Thu, 24 Apr 2025
Enfusion (ENFN) Stock Price, News & Analysis - Stock Titan
Mon, 21 Apr 2025
Clearwater Analytics Finalizes Acquisition of Enfusion - Business Wire
Thu, 10 Apr 2025
Clearwater Analytics to Acquire Enfusion: Everything Investors Need to Know(ENFN, CWAN Merger) - tradingcalendar.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|